Featuring an interview with Dr Debra Richardson, including the following topics:
- Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors (0:00)
- Activity, safety and ongoing investigation of tumor treating fields in combination with chemotherapy for advanced ovarian cancer (5:12)
- ASCO and SGO guidance on the nationwide shortages of carboplatin and cisplatin (9:21)
- Investigating mechanisms of resistance to PARP inhibitors; potential use of circulating tumor DNA as an investigational tool (14:13)
CME information and select publications